Cerus (CERS) Operating Margin (QoQ) (2010 - 2026)
Cerus (CERS) Operating Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.08 Bn | 196.48 Bn | 7.27 Bn |
| 2 | Stryker | 126.51 Bn | 123.03 Bn | 4.50 Bn |
| 3 | Medtronic | 119.52 Bn | 110.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn |
| 6 | Dexcom | 34.86 Bn | 32.91 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.26 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Cerus | 573.62 Mn | 517.35 Mn | 29.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -257.00 |
| Mar 31, 2026 | -18.00 |
| Dec 31, 2025 | -1,688.00 |
| Sep 30, 2025 | 64,217.00 |
| Jun 30, 2025 | -61,224.00 |
| Mar 31, 2025 | -1,152.00 |
| Dec 31, 2024 | 13,606.00 |
| Sep 30, 2024 | -12,533.00 |
| Jun 30, 2024 | 805.00 |
| Mar 31, 2024 | -2,132.00 |
| Dec 31, 2023 | 299,653.00 |
| Sep 30, 2023 | -296,604.00 |
| Jun 30, 2023 | 7,088.00 |
| Mar 31, 2023 | -9,552.00 |
| Dec 31, 2022 | 10,465.00 |
| Sep 30, 2022 | -9,330.00 |
| Jun 30, 2022 | 4,986.00 |
| Mar 31, 2022 | -6,044.00 |
| Dec 31, 2021 | 18,028.00 |
| Sep 30, 2021 | -8,804.00 |